Koyfin Home > Directory > Health Care > Amneal Pharmaceuticals Inc > Cost of Goods Sold

Amneal Pharmaceuticals Inc Cost of Goods Sold Chart (AMRX)

Amneal Pharmaceuticals Inc annual/quarterly Cost of Goods Sold from 2016 to 2018.
  • Amneal Pharmaceuticals Inc Cost of Goods Sold for the quarter ending December 12, 2018 was $307m a 59.06% increase of 182m year over year
  • Amneal Pharmaceuticals Inc Cost of Goods Sold for the last 12 months ending December 12, 2018 was $963m a 48.88% increase of 471m year over year
  • Amneal Pharmaceuticals Inc Annual Cost of Goods Sold for 2018 was $963m a 50.46% increase of 486m from 2017
  • Amneal Pharmaceuticals Inc Annual Cost of Goods Sold for 2017 was $477m a 10.23% increase of 49m from 2016
  • Amneal Pharmaceuticals Inc Annual Cost of Goods Sold for 2016 was $428m a 14.28% increase of 61m from 2015
Other Income Statement Metrics:
  • Amneal Pharmaceuticals Inc EBITDA for the quarter ending December 12, 2018 was $109m a 21.60% increase of 24m year over year
  • Amneal Pharmaceuticals Inc Net Income for the quarter ending December 12, 2018 was $-9m a 687.76% decrease of -60m year over year
  • Amneal Pharmaceuticals Inc Total Revenue for the quarter ending December 12, 2018 was $498m a 44.69% increase of 222m year over year
View Chart On Koyfin

Quarterly AMRX Cost of Goods Sold Data

12/2018$307m
09/2018$263m
06/2018$240m
03/2018$126m
12/2017$133m
09/2017$126m
06/2017$141m
03/2017$111m
12/2016$122m

Annual AMRX Cost of Goods Sold Data

2018$963m
2017$477m
2016$428m
2015$367m
2014$336m